To assess the in vivo role of TSP-1 in the absence of FH, we used FH-deficient mice, an established model for complement overactivation, characterized by low serum C3 levels and extensive C3 deposition within the kidneys, resembling C3 glomerulopathy (29). This evidence concerns the gene C3 and complement 3 glomerulopathy.